Hafsah Nabi

5PUBLICATIONS
21CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 29, 2025
Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care.

Hafsah Nabi, Kasper Yde Jensen, Rasmus Westermann

|Nov 01, 2024
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients.

Hafsah Nabi, Rikke Ibsen, Michael Ibsen

|Nov 23, 2022
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry.

Hafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen

|Sep 27, 2021
Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study.

Daniel H Tajchman, Hafsah Nabi, Mohsin Aslam

|Apr 30, 2021
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.

Hafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft

Pageof 1

Frequent Collaborators

2 joint publications

Stavros Chrysidis

2 joint publications

Bente Glintborg

2 joint publications

Salome Kristensen

2 joint publications

Merete Lund Hetland